Open Access
J Extra Corpor Technol
Volume 55, Number 3, September 2023
Page(s) 105 - 111
Published online 08 September 2023
  1. Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J (2004) Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery? J Thorac Cardiovasc Surg 128, 211–219. [CrossRef] [PubMed] [Google Scholar]
  2. Taneja R, Marwaha G, Sinha P, et al. (2009) Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery. Can J Anaesth 56, 489–496. [CrossRef] [PubMed] [Google Scholar]
  3. Ichikawa J, Kodaka M, Nishiyama K, Hirasaki Y, Ozaki M, Komori M (2014) Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 28, 1003–1007. [CrossRef] [PubMed] [Google Scholar]
  4. Boer C, Meesters MI, Veerhoek D, Vonk AB (2018) Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth 120, 914–927. [CrossRef] [PubMed] [Google Scholar]
  5. Jobes DR, Aitken GL, Shaffer GW (1995) Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 110, 36–45. [CrossRef] [PubMed] [Google Scholar]
  6. Koster A, Börgermann J, Gummert J, Rudloff M, Zittermann A, Schirmer U (2014) Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study. Clin Appl Thromb Hemost 20, 290–295. [CrossRef] [PubMed] [Google Scholar]
  7. Meesters MI, Veerhoek D, de Lange F, et al. (2016) Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. Thromb Haemost 116, 251–261. [CrossRef] [PubMed] [Google Scholar]
  8. Kunz SA, Miles LF, Ianno DJ, et al. (2018) The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass. Perfusion 33, 445–452. [CrossRef] [PubMed] [Google Scholar]
  9. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH (1998) Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 87, 781–785. [CrossRef] [PubMed] [Google Scholar]
  10. Abuelkasem E, Mazzeffi MA, Henderson RA, et al. (2019) Clinical impact of protamine titration-based heparin neutralization in patients undergoing coronary bypass grafting surgery. J Cardiothorac Vasc Anesth 33, 2153–2160. [CrossRef] [PubMed] [Google Scholar]
  11. Lindblad B, Wakefield TW, Whitehouse WM, Stanley JC (1988) The effect of protamine sulfate on platelet function. Scand J Thorac Cardiovasc Surg 22, 55–59. [CrossRef] [PubMed] [Google Scholar]
  12. Ammar T, Fisher CF (1997) The effects of heparinase 1 and protamine on platelet reactivity. Anesthesiology 86, 1382–1386. [CrossRef] [PubMed] [Google Scholar]
  13. Shigeta O, Kojima H, Hiramatsu Y, et al. (1999) Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 118, 354–360. [CrossRef] [PubMed] [Google Scholar]
  14. Comunale ME, Maslow A, Robertson LK, Haering JM, Mashikian JS, Lowenstein E (2003) Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 17, 309–313. [CrossRef] [PubMed] [Google Scholar]
  15. Mclaughlin KE, Dunning J (2003) In patients post cardiac surgery do high doses of protamine cause increased bleeding? Interact Cardiovasc Thorac Surg 2, 424–426. [CrossRef] [PubMed] [Google Scholar]
  16. Nybo M, Madsen JS (2008) Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 103, 192–196. [CrossRef] [PubMed] [Google Scholar]
  17. De Simone F, Nardelli P, Licheri M, et al. (2021) Less is more: We are administering too much protamine in cardiac surgery. Ann Card Anaesth 24, 178–182. [CrossRef] [PubMed] [Google Scholar]
  18. Valchanov K, Falter F, George S, et al. (2019) Three cases of anaphylaxis to protamine: management of anticoagulation reversal. J Cardiothorac Vasc Anesth 33, 482–486. [CrossRef] [PubMed] [Google Scholar]
  19. Hecht P, Besser M, Falter F (2020) Are we able to dose protamine accurately yet? A review of the protamine conundrum. J Extra Corpor Technol 52, 63–70. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Cuenca JS, Diz PG, Sampedro FG, Zincke JM, Acuña HR, Fontanillo MM (2013) Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgery. J Extra Corpor Technol 45, 235. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  21. Davidsson FÖ, Johagen D, Appelblad M, Svenmarker S (2015) Reversal of heparin after cardiac surgery: protamine titration using a statistical model. J Cardiothorac Vasc Anesth 29, 710–714. [CrossRef] [PubMed] [Google Scholar]
  22. Suelzu S, Cossu A, Pala G, et al. (2015) Impact of different dosage of protamine on heparin reversal during off-pump coronary artery bypass: a clinical study. Heart Lung Vessel 7, 238. [PubMed] [Google Scholar]
  23. Meesters MI, Veerhoek D, de Jong JR, Boer C (2016) A pharmacokinetic model for protamine dosing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 30, 1190–1195. [CrossRef] [PubMed] [Google Scholar]
  24. Hällgren O, Svenmarker S, Appelblad M (2017) Implementing a statistical model for protamine titration: effects on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 31, 516–521. [CrossRef] [PubMed] [Google Scholar]
  25. Goedhart AL, Gerritse BM, Rettig TC, et al. (2020) A 0.6-protamine/heparin ratio in cardiac surgery is associated with decreased transfusion of blood products. Interact Cardiovasc Thorac Surg 31, 391–397. [CrossRef] [PubMed] [Google Scholar]
  26. Khan NU, Wayne CK, Barker J, Strang T (2010) The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 27, 624–627. [CrossRef] [PubMed] [Google Scholar]
  27. Lee MH, Riley W, Shann KG (2021) Can the minimum protamine dose to neutralize heparin at the completion of cardiopulmonary bypass be significantly lower than the conventional practice? J Extra Corpor Technol 53, 170–176. [PubMed] [Google Scholar]
  28. Lee MH, Gisnarian CJ, Shann KG (2019) Improved estimation of total blood volume can provide a reliable prediction of dilutional hematocrit and oxygen delivery during cardiopulmonary bypass. J Extra Corpor Technol 51, 67–72. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  29. Lee MH, Riley W (2021) Factors associated with errors in the heparin dose response test: Recommendations to improve individualized heparin management in cardiopulmonary bypass. Perfusion 36, 513–523. [CrossRef] [PubMed] [Google Scholar]
  30. Du Bois D, Du Bois EF (1916) Clinical calorimetry: tenth paper a formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17, 863–871. [CrossRef] [Google Scholar]
  31. Allen TH, Peng MT, Chen KP, Huang TF, Chang C, Fang HS (1956) Prediction of blood volume and adiposity in man from body weight and cube of height. Metabolism 5, 328–345. [PubMed] [Google Scholar]
  32. Ural K, Owen C (2016) Pro: The Hepcon HMS should be used instead of traditional activated clotting time (ACT) to dose heparin and protamine for cardiac surgery requiring cardiopulmonary bypass. J Cardiothorac Vasc Anesth 30, 1727–1729. [CrossRef] [PubMed] [Google Scholar]
  33. Kjellberg G, Holm M, Fux T, Lindvall G, van der Linden J (2019) Calculation algorithm reduces protamine doses without increasing blood loss or the transfusion rate in cardiac surgery: results of a randomized controlled trial. J Cardiothorac Vasc Anesth 33, 985–992. [CrossRef] [PubMed] [Google Scholar]
  34. Shore-Lesserson L, Reich DL, DePerio M (1998) Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Can J Anaesth 45, 10–18. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.